DSpace
Universidad de Navarra

Dadun >
Depósito Académico >
CIFA (Centro de Investigación en Farmacobiología Aplicada) >
Unidad de I+D de Medicamentos >
DA - CIFA - I+D de medicamentos - Artículos de revistas >

Statistics
Please use this identifier to cite or link to this item: http://hdl.handle.net/10171/18730

Title: Aryl piperazine and pyrrolidine as antimalarial agents. Synthesis and investigation of structure-activity relationships
Author(s) : Mendoza, A. (Adela)
Perez-Silanes, S. (Silvia)
Quiliano, M. (Miguel)
Pabon, A. (Adriana)
Galiano, S. (S.)
Gonzalez, G. (Germán)
Garavito, G. (G.)
Zimic, M. (Mirko)
Vaisberg, A. (Abrahm)
Aldana, I. (Ignacio)
Monge, A. (Antonio)
Deharo, E. (E.)
Issue Date: 2011
Publisher: Elsevier
Citation: Mendoza A, Perez-Silanes S, Quiliano M, Pabon A, Galiano S, Gonzalez G, et al. Aryl piperazine and pyrrolidine as antimalarial agents. Synthesis and investigation of structure-activity relationships. Exp Parasitol 2011 Jun;128(2):97-103.
Keywords: Piperazine
Pyrrolidine
Antiplasmodial
Plasmodium
Antimalarial agents
Docking studies
Abstract: Piperazine and pyrrolidine derivatives were synthesized and evaluated for their capacity to inhibit the growth of Plasmodium falciparum chloroquine-resistant (FCR-3) strain in culture. The combined presence of a hydroxyl group, a propane chain and a fluor were shown to be crucial for the antiplasmodial activity. Five compounds of the aryl-alcohol series inhibited 50% of parasite growth at doses ≤ 10 µM. The most active compound 1-(4-fluoronaphthyl)-3-[4-(4-nitro-2-trifluoromethylphenyl)piperazin-1-yl]propan-1-ol was almost 20 to 40 times more active on Plasmodium falciparum (IC50: 0.5 µM) than on tumorogenic and non tumorogenic cells. Calculated physicochemical parameters showed a good potential for intestinal absorption, but due to difficulty in being solubilised prior to oral administration, it was weakly active against Plasmodium berghei infected mice (ED50: 35%). In silico molecular docking study and molecular electrostatic potential calculation revealed that this compound bound to the active site of Plasmodium plasmepsin II enzyme.
URI: http://hdl.handle.net/10171/18730
Publisher version (URL): http://dx.doi.org/10.1016/j.exppara.2011.02.025
Appears in Collections:DA - Farmacia - Orgánica - Artículos de revista
DA - CIFA - I+D de medicamentos - Artículos de revistas

Files in This Item:

File Description SizeFormat
Experimental Parasitology, 128, 97-103.pdf940,5 kBAdobe PDFView/Open
Statistics

Import into RefWorks

SFX Query

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2010  Duraspace - Feedback